These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27531201)

  • 1. "Adaptive pathways" to drug authorisation: adapting to industry?
    Davis C; Lexchin J; Jefferson T; Gøtzsche P; McKee M
    BMJ; 2016 Aug; 354():i4437. PubMed ID: 27531201
    [No Abstract]   [Full Text] [Related]  

  • 2. Law, medicines and the doctor: a critical look at drug regulation.
    Dukes MN
    Curr Med Res Opin; 1973; 1(10):612-28. PubMed ID: 4778727
    [No Abstract]   [Full Text] [Related]  

  • 3. European Medicines Agency assesses safety reporting at Roche.
    Marshall H
    Lancet Oncol; 2012 Aug; 13(8):e331. PubMed ID: 23024993
    [No Abstract]   [Full Text] [Related]  

  • 4. Why the drug development pipeline is not delivering better medicines.
    Naci H; Carter AW; Mossialos E
    BMJ; 2015 Oct; 351():h5542. PubMed ID: 26496934
    [No Abstract]   [Full Text] [Related]  

  • 5. [Discouraging about drug therapy?].
    Reseland S
    Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1910-1. PubMed ID: 12830286
    [No Abstract]   [Full Text] [Related]  

  • 6. European Medicines Agency is attacked over proposal to allow technology assessment bodies to sell advice to drug industry.
    Wise J
    BMJ; 2014 Jul; 349():g4674. PubMed ID: 25033980
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug therapy].
    Aarbakke J; Rasmussen K
    Tidsskr Nor Laegeforen; 2003 Feb; 123(4):476-7. PubMed ID: 12643062
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjustment of Europe's drug regulation to public-health needs.
    Thirstrup S; Kampmann JP
    Lancet; 2001 Nov; 358(9294):1734. PubMed ID: 11728590
    [No Abstract]   [Full Text] [Related]  

  • 9. The drug regulatory system of the United States Food and Drug Administration: a defense of current requirements for safety and efficacy.
    Simmons HE
    Int J Health Serv; 1974; 4(1):95-107. PubMed ID: 4829901
    [No Abstract]   [Full Text] [Related]  

  • 10. Symposium on drug safety. The role of regulatory agencies and industry in assessment of the safety of drugs for use in man. The situation in the United Kingdom.
    Cahal DA
    Can Med Assoc J; 1968 Feb; 98(6):271-5. PubMed ID: 5636096
    [No Abstract]   [Full Text] [Related]  

  • 11. A lifecycle approach to the evaluation of FDA approval methods and regulatory actions: opportunities provided by a new IOM report.
    Psaty BM; Meslin EM; Breckenridge A
    JAMA; 2012 Jun; 307(23):2491-2. PubMed ID: 22563032
    [No Abstract]   [Full Text] [Related]  

  • 12. [Contact and dialogue between drug companies and the global regulatory authorities throughout research and development phase].
    Kock M; Thomsen MK
    Ugeskr Laeger; 2003 Apr; 165(16):1649-52. PubMed ID: 12756820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary by a child psychiatrist in industry on the assessment of drug safety.
    Allen AJ
    J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):288-91. PubMed ID: 17630860
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sweden can contribute to safer drug assessment].
    Strandberg K
    Lakartidningen; 2006 Jun 8-13; 103(23):1853-5. PubMed ID: 16838598
    [No Abstract]   [Full Text] [Related]  

  • 15. European drug agency under fire: critics charge that trial data are too inaccessible.
    Hampton T
    JAMA; 2011 Aug; 306(6):593-5. PubMed ID: 21828315
    [No Abstract]   [Full Text] [Related]  

  • 16. Determinants for successful marketing authorisation of orphan medicinal products in the EU.
    Putzeist M; Heemstra HE; Garcia JL; Mantel-Teeuwisse AK; Gispen-De Wied CC; Hoes AW; Leufkens HG
    Drug Discov Today; 2012 Apr; 17(7-8):352-8. PubMed ID: 22094244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Regulation and Pricing--Can Regulators Influence Affordability?
    Eichler HG; Hurts H; Broich K; Rasi G
    N Engl J Med; 2016 May; 374(19):1807-9. PubMed ID: 27168431
    [No Abstract]   [Full Text] [Related]  

  • 18. Crying wolf on drug safety.
    Br Med J (Clin Res Ed); 1982 Jan; 284(6311):219-20. PubMed ID: 6799107
    [No Abstract]   [Full Text] [Related]  

  • 19. Post-marketing strategies for medicines.
    Breckenridge A
    Clin Pharmacol Ther; 2008 Jan; 83(1):24-5; discussion 25. PubMed ID: 18043682
    [No Abstract]   [Full Text] [Related]  

  • 20. [Increased commercial financing of national Medical Product Agencies within the EU].
    Ramel B
    Lakartidningen; 2003 Jan; 100(5):338-9. PubMed ID: 12607381
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.